54 results
Page 2 of 3
8-K
EX-99.1
qs02z4wl74ku6zh4iyu
12 Nov 21
ALX Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
8:26am
8-K
EX-99.1
q33 wh30xkc7
7 Oct 21
ALX Oncology Strengthens Immuno-Oncology Pipeline with Acquisition of ScalmiBio
7:38am
S-3ASR
i5hw5wsi6f b8j9b4ad
13 Aug 21
Automatic shelf registration
4:31pm
8-K
EX-99.1
db4fwyyaubttuwehb
12 Aug 21
ALX Oncology Reports Second Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
4:18pm
8-K
EX-99.1
r9h6odm p9q
17 May 21
ALX Oncology Reports First Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
4:10pm
10-K
fwz966xeqnwxtu 9nlhn
18 Mar 21
Annual report
4:25pm
10-K
EX-4.3
m8xrhj
18 Mar 21
Annual report
4:25pm
8-K
EX-99.1
kdjc5v is7wpw
18 Mar 21
Results of Operations and Financial Condition
4:11pm
8-K
EX-99.1
4m5u8h6jnvzy
15 Mar 21
ALX Oncology Announces Appointment of Sophia Randolph, M.D., Ph.D., to Board of Directors
8:30am
424B4
kobuf4pxa ipcx8z5u
11 Dec 20
Prospectus supplement with pricing info
12:00am
DRS
wpe6j8w2qpet
24 Nov 20
Draft registration statement
12:00am
8-K
EX-99.1
nh3lkor
12 Nov 20
ALX Oncology Reports Third Quarter 2020 Financial Results and Provides Clinical Development and Operational Highlights
4:20pm
10-Q
vmckijneb 6dmlzq6
27 Aug 20
Quarterly report
4:49pm
8-K
EX-99.1
nxn8bq4m0nz
27 Aug 20
ALX Oncology Reports Second Quarter 2020 Financial Results and Provides Operational and Clinical Highlights
4:16pm